News
Mundipharma Establishes an Ophthalmology Business by Acquiring MSD's...
www.finanznachrichten.de
- The portfolio consists of COSOPT®, COSOPT® Preservative-Free, SAFLUTAN®, TIMOPTIC®, TIMOPTIC XE®, TIMOPTIC® Preservative-Free, TRUSOPT® and TRUSOPT®...
News for Medical Independent Sales Representatives and Medical...
salesandmarketingnetwork.com
Healthcare Sales & Marketing Network: Merck Acquires Development and Commercialization Rights to Investigational mTOR Inhibitor Ridaforolimus from ARIAD...
Mundipharma Acquires Merck’s Ophthalmology Portfolio | |...
www.fdanews.com
In a statement, Muna Bhanji, president of hospital and specialty care at MSD — Merck's name outside the U.S. and Canada — says the ...
Mundipharma buys Merck's ophthalmology business
www.biospectrumasia.com
Mundipharma establishes an ophthalmology business by acquiring Merck's portfolio of glaucoma products
sortiert nach Relevanz / Datum